Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at William Blair boosted their Q3 2018 EPS estimates for shares of Henry Schein in a research note issued on Wednesday, according to Zacks Investment Research. William Blair analyst J. Kreger now anticipates that the company will post earnings per share of $1.14 for the quarter, up from their prior estimate of $1.06.
Other equities research analysts also recently issued reports about the company. Stephens assumed coverage on Henry Schein in a research report on Tuesday, November 28th. They issued an “equal weight” rating and a $76.00 target price on the stock. TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a research report on Monday, November 6th. Credit Suisse Group reiterated a “neutral” rating and issued a $80.00 target price (down from $87.50) on shares of Henry Schein in a research report on Tuesday, November 28th. Stifel Nicolaus decreased their target price on Henry Schein from $89.00 to $77.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Finally, Jefferies Group decreased their target price on Henry Schein from $89.00 to $74.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $84.23.
Henry Schein (NASDAQ:HSIC) traded down $0.93 during trading hours on Friday, hitting $74.35. The company had a trading volume of 1,342,773 shares, compared to its average volume of 1,518,127. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $11,669.53, a P/E ratio of 21.43, a P/E/G ratio of 1.91 and a beta of 1.00. Henry Schein has a 12 month low of $65.28 and a 12 month high of $93.50.
Several institutional investors and hedge funds have recently added to or reduced their stakes in HSIC. Alecta Pensionsforsakring Omsesidigt grew its stake in shares of Henry Schein by 112.0% during the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock valued at $435,693,000 after buying an additional 2,806,990 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Henry Schein by 106.0% during the third quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock valued at $322,896,000 after buying an additional 2,026,867 shares during the last quarter. Janus Henderson Group PLC grew its stake in shares of Henry Schein by 92.1% during the third quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock valued at $230,777,000 after buying an additional 1,349,333 shares during the last quarter. Atlanta Capital Management Co. L L C grew its stake in shares of Henry Schein by 99.4% during the third quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock valued at $204,405,000 after buying an additional 1,242,849 shares during the last quarter. Finally, Neuberger Berman Group LLC grew its stake in shares of Henry Schein by 95.9% during the third quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock valued at $202,930,000 after buying an additional 1,211,743 shares during the last quarter. 91.10% of the stock is currently owned by hedge funds and other institutional investors.
In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the sale, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.19% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Henry Schein, Inc. to Post Q3 2018 Earnings of $1.14 Per Share, William Blair Forecasts (HSIC)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/04/henry-schein-inc-hsic-to-post-q3-2018-earnings-of-1-14-per-share-william-blair-forecasts.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Get a free copy of the Zacks research report on Henry Schein (HSIC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.